- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: HER2 negative
Total 7734 results
-
Samsung Bioepis Co., Ltd.TerminatedBreast NeoplasmsUkraine, Romania, Russian Federation, France, Bulgaria, Czechia, Poland
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer Metastatic | HER2 Gene Mutation | Non Small Cell Lung Cancer Stage IIIFrance
-
Yonsei UniversityCompletedHER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract CancerKorea, Republic of
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedCarcinoma, Non-Small-Cell Lung | KRAS Gene Mutation | ALK Gene Mutation | BRAF Gene MutationFrance
-
Helsinki University Central HospitalActive, not recruiting
-
Bellicum PharmaceuticalsSuspendedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Solid Tumor, Adult | HER-2 Gene Amplification | HER-2 Protein OverexpressionUnited States
-
Cancer Trials IrelandTerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CancerIreland, Spain
-
Fudan UniversityJiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
Fate TherapeuticsCompletedMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | HER2-positive Breast Cancer | Head and Neck Squamous Cell Carcinoma | HER2 Positive Gastric Cancer | EGFR Positive Solid TumorUnited States
-
NSABP Foundation IncGenentech, Inc.; International Drug Development InstituteCompleted
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastSpain, United States, Argentina, Austria, Italy, Russian Federation, Thailand, Brazil, Peru, Philippines, Hong Kong, Mexico
-
Zhejiang Medicine Co., Ltd.Ambrx, Inc.TerminatedStomach Neoplasms | Breast NeoplasmsAustralia, New Zealand
-
Asan Medical CenterHoffmann-La RocheCompletedMetastatic or Recurrent Gastric Adenocarcinoma | Her-2 Positive Gastric CancerKorea, Republic of
-
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.Shenzhen Second People's HospitalUnknown
-
NantBioScience, Inc.Unknown
-
United BioPharmaTri-Service General HospitalCompleted
-
SOLTI Breast Cancer Research GroupNovartisCompleted
-
Puma Biotechnology, Inc.CompletedBreast CancerUnited States, Spain, China, Hungary, Singapore, Australia, Russian Federation, Hong Kong, Brazil, Croatia, Korea, Republic of
-
University of LeipzigGerman Federal Ministry of Education and ResearchCompletedStomach Neoplasms | Esophageal NeoplasmsGermany
-
First Affiliated Hospital of Harbin Medical UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUnknownPancreatic Cancer | CARChina
-
Baylor Breast Care CenterAstraZenecaTerminated
-
AIO-Studien-gGmbHRoche Pharma AGCompletedAdenocarcinoma of the Gastroesophageal Junction | Adenocarcinoma of the StomachGermany
-
British Columbia Cancer AgencyBC Cancer FoundationCompletedGastrointestinal Stromal Tumors | Colorectal Cancer Metastatic | Advanced Melanoma | Advanced Non-Small Cell Lung Carcinoma | Patients With Diagnosed Malignancies Being Considered for Clinical TrialsCanada
-
Galena Biopharma, Inc.CompletedBreast Cancer With Low to Intermediate HER2 ExpressionUnited States, United Kingdom, France, Israel, Germany, Canada, Russian Federation, Romania, Bulgaria, Czech Republic, Hungary, Poland, Ukraine
-
Genentech, Inc.Completed
-
Novartis PharmaceuticalsTerminatedMetastatic Breast Cancer | HER2+ Breast CancerBelgium, France, Spain, United States, United Kingdom, Italy
-
Genentech, Inc.CompletedMetastatic Breast CancerUnited States
-
Nantes University HospitalTerminatedRelapsed/Refractory LeukemiaFrance
-
Biomedical Radiation SciencesSwedish Cancer SocietyCompleted
-
Genentech, Inc.Completed
-
GlaxoSmithKlineWithdrawn
-
Zhimin ShaoRoche Pharma AGUnknownHER-2 Positive Breast CancerChina
-
su haichuanNot yet recruiting
-
Xijing HospitalNot yet recruitingHER2-positive Breast Cancer and Gastric Cancer
-
Peking University Cancer Hospital & InstituteRecruitingHER2 Positive or Suspicious Positive TumorsChina
-
Alphamab (Australia) Co Pty Ltd.RecruitingAdvanced Solid Tumors | Metastatic Solid TumorsAustralia
-
Beijing 302 HospitalRecruiting
-
SystImmune Inc.RecruitingCervical Cancer | Ovarian Cancer | Endometrial Cancer | Urothelial Carcinoma | Biliary Tract CancerUnited States
-
University of SouthamptonAstraZeneca; Natera, Inc.RecruitingGastrooesophageal CancerUnited Kingdom
-
Amsterdam UMC, location VUmcAstraZenecaRecruitingBreast Cancer | Gastric Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric CancerNetherlands
-
Seagen Inc.Merck Sharp & Dohme LLC; RemeGen Co., Ltd.RecruitingUrothelial CarcinomaUnited States, Canada, Australia, Singapore
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, Italy, China, Korea, Republic of, Canada, Japan, Netherlands
-
Shanghai Miracogen Inc.RecruitingBreast Cancer With Liver MetastasesChina
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingEsophageal Cancer | Esophageal AdenocarcinomaNetherlands
-
Shanghai Miracogen Inc.RecruitingLocally Advanced Gastric Cancer | Metastatic HER2 Positive Gastroesophageal Junction CancerChina
-
Shanghai Miracogen Inc.RecruitingAdvanced Solid TumorChina
-
Shanghai Miracogen Inc.RecruitingAdvanced or Metastatic Biliary Tract CancerChina
-
Shanghai PerHum Therapeutics Co., Ltd.Shanghai Zhongshan HospitalRecruitingSarcoma | Breast Cancer | Gastric Cancer | Ovarian Cancer | Solid TumorChina
-
AstraZenecaDaiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, TokyoRecruitingGastric CancerChina, Spain, Korea, Republic of, Canada, Italy, Poland, Japan, United Kingdom, Brazil, Taiwan, United States, Germany, Netherlands, Russian Federation
-
Herbert LyerlyRecruiting